Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Datroway
Pharma
AZ sets sights on 25+ blockbusters by 2030
Analysts are heavily focused on AZ’s clinical programs, wondering whether it can repeat the level of phase 3 successes it enjoyed last year.
Angus Liu
Feb 10, 2026 11:20am
OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia
Feb 6, 2026 9:48am
Daiichi Sankyo navigates complexity of success
Jan 26, 2026 11:11am
AZ's $80B revenue target 'very much within reach,' CFO says
Jan 14, 2026 10:00am
Merck partner Kelun touts ph. 3 win for ADC in first-line NSCLC
Nov 24, 2025 10:56am
Merck grows more ambitious about 'workhorse' TROP2 ADC
Oct 20, 2025 4:00pm
